Physician profile
Brian Kiesnowski
NPI 1285607317
$195,642.77
in general payments reported to CMS, 2019-2025
14 companies · $7,908 in 2025
The $7,908 reported for 2025 was more than what 94% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $14K · 2021: $25K · 2022: $25K · 2023: $25K · 2024: $9,740 · 2025: $7,908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $32K · Travel and Lodging: $7,100 · Long Term Medical Supply Or Device Loan: $2,329 · Food and Beverage: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,628.13 |
| Travel and Lodging | $7,099.82 |
| Long Term Medical Supply Or Device Loan | $2,328.75 |
| Food and Beverage | $1,349.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $160,810.91 | 2019-2025 | Stravix, Grafix Pl, Stravix Pl |
| Osiris Therapeutics INC. | $32,035.57 | 2019 | |
| Integra Lifesciences Corporation | $2,340.60 | 2022-2025 | Durasorb Monofilament Mesh |
| Glaxosmithkline, LLC. | $119.64 | 2022 | |
| Kci USA, INC. | $111.88 | 2019 | |
| Mentor Worldwide LLC | $45.76 | 2019-2024 | Artoura Breast Tissue Expander |
| Pacira Pharmaceuticals Incorporated | $38.66 | 2022-2023 | Exparel, Iovera, Zilretta |
| Abbvie INC. | $31.28 | 2024 | |
| Allergan, INC. | $30.30 | 2022 | |
| Organogenesis INC. | $24.07 | 2025 | Puraply Wound Matrix |
| W. L. Gore & Associates, INC. | $16.36 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Galderma Laboratories, L.P. | $13.79 | 2019 | |
| Misonix INC | $12.82 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kiesnowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.